Correlation Between Quoin Pharmaceuticals and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Akari Therapeutics PLC, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Akari Therapeutics.
Diversification Opportunities for Quoin Pharmaceuticals and Akari Therapeutics
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Quoin and Akari is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Quoin Pharmaceuticals and Akari Therapeutics
Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to generate 1.31 times more return on investment than Akari Therapeutics. However, Quoin Pharmaceuticals is 1.31 times more volatile than Akari Therapeutics PLC. It trades about 0.11 of its potential returns per unit of risk. Akari Therapeutics PLC is currently generating about -0.17 per unit of risk. If you would invest 48.00 in Quoin Pharmaceuticals Ltd on September 4, 2024 and sell it today you would earn a total of 16.00 from holding Quoin Pharmaceuticals Ltd or generate 33.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Quoin Pharmaceuticals Ltd vs. Akari Therapeutics PLC
Performance |
Timeline |
Quoin Pharmaceuticals |
Akari Therapeutics PLC |
Quoin Pharmaceuticals and Akari Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Quoin Pharmaceuticals and Akari Therapeutics
The main advantage of trading using opposite Quoin Pharmaceuticals and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.Quoin Pharmaceuticals vs. Candel Therapeutics | Quoin Pharmaceuticals vs. Cingulate Warrants | Quoin Pharmaceuticals vs. Unicycive Therapeutics | Quoin Pharmaceuticals vs. Cardio Diagnostics Holdings |
Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |